Austin: 512-339-4040 Lakeway: 512-682-4798 Marble Falls: 830-992-2830 Dripping Springs: 512-339-4040
Patient Portal Pay Bill
CPAP Alternative

Inspire Therapy
for Sleep Apnea

Sleep apnea treatment without a mask, hose, or machine. Inspire is an FDA-approved implant that keeps your airway open while you sleep, activated by a simple remote control at bedtime. Capital ENT has offered Inspire for over 10 years, with a few hundred patients implanted across Central Texas.

CPAP Alternative

What is Inspire therapy?

Inspire is an FDA-approved implantable neurostimulator that treats moderate-to-severe obstructive sleep apnea (OSA) by stimulating the hypoglossal nerve to keep the airway open during sleep. The device is placed under the skin of the upper chest during a short outpatient procedure under general anesthesia. Unlike CPAP, there is no mask, no hose, and no machine; patients turn it on with a small remote at bedtime. The device monitors your breathing and delivers mild stimulation that gently moves the tongue and airway muscles forward while you sleep.

Inspire is specifically designed for patients who cannot tolerate or do not benefit from CPAP therapy. You simply press a button on a small remote control at bedtime to turn it on and press again in the morning to turn it off. Capital ENT has been offering Inspire therapy for over 10 years and has treated hundreds of patients across Central Texas.

  • FDA-approved for moderate-to-severe obstructive sleep apnea
  • No mask, no hose, no machine. Just a small remote at bedtime
  • Implanted during a short outpatient procedure
  • Over 10 years of Inspire experience at Capital ENT
  • Hundreds of patients treated across Central Texas
  • Most major insurance plans accepted, including Medicare
Patient using Inspire therapy remote at bedtime
10+
Years Offering Inspire Therapy in Austin
100s
Of Inspire Patients Treated at Capital ENT
84%
Average AHI Reduction in Our Patients
4
Convenient Central Texas Locations
Why Treatment Matters

What Untreated Sleep Apnea Does to Your Body

Sleep apnea is not just snoring or daytime fatigue. When left untreated, moderate-to-severe obstructive sleep apnea creates a cycle of repeated oxygen deprivation that stresses the heart, brain, and metabolic system in ways that accumulate over years. This is why our specialists treat moderate-to-severe OSA as a medical condition requiring consistent management, not a lifestyle nuisance to ignore.

Cardiovascular Risk

Untreated moderate-to-severe OSA is independently associated with high blood pressure, atrial fibrillation, heart failure, and elevated stroke risk. Each apnea event triggers a surge of sympathetic nervous system activity that stresses the heart throughout the night.

Metabolic Consequences

Fragmented sleep impairs insulin sensitivity and is linked to higher rates of type 2 diabetes and metabolic syndrome. Effective OSA treatment has been shown to support better blood sugar regulation in many patients and improve metabolic markers over time.

Daytime Function

Excessive daytime sleepiness from OSA significantly increases the risk of motor vehicle accidents. Cognitive effects including memory impairment, slowed reaction time, and difficulty concentrating accumulate over years of untreated disease and often go unrecognized as sleep-related.

Sleep Architecture

Most patients with untreated moderate-to-severe OSA never reach the deep, restorative sleep stages the body requires. No amount of extra time in bed compensates for sleep that is constantly interrupted. Restoring continuous sleep changes how patients feel, function, and age.

For CPAP-Intolerant Patients

Going untreated is not a neutral choice

The AASM estimates that 80 to 90 percent of adults with moderate-to-severe OSA remain undiagnosed or inadequately treated. Among those who are diagnosed and prescribed CPAP, long-term adherence rates are low: studies consistently find that 30 to 50 percent of CPAP patients use their machine fewer than 4 hours per night, below the threshold for effective therapy.

For these patients, Inspire offers a path to consistent, effective treatment without nightly mask compliance. When a patient cannot or will not use CPAP, Inspire is not an elective upgrade: it is the medically appropriate next step.

Austin, Texas

Sleep apnea in Central Texas

Central Texas presents specific challenges for sleep apnea patients. The region's intense cedar, oak, and mountain cedar allergy season runs nearly year-round, causing nasal congestion that worsens upper airway obstruction and makes CPAP tolerance even harder. Many patients find that CPAP compliance drops sharply during peak allergy months.

Austin's population also skews younger and more active than the national average, which can delay diagnosis. Active, otherwise healthy adults often attribute daytime fatigue to work stress rather than a sleep disorder. Capital ENT has provided Inspire therapy to hundreds of patients across Austin, Lakeway, Marble Falls, and Dripping Springs, many of whom came to us after years of inadequate CPAP compliance.

Proven Results

Capital ENT Patient Outcomes

Our Inspire patients experience dramatic improvement in sleep apnea severity, measured by the Apnea-Hypopnea Index (AHI).

Average AHI: Before & After Inspire
Apnea-Hypopnea Index (events per hour of sleep)
0 5 10 15 20 25 30 35 40
31
Severe
Before Inspire Pre-op Average
5
After Inspire Post-op Average

Based on average AHI scores from Capital ENT Inspire patients. Individual results may vary.

The Process

How Inspire Therapy Works

From initial evaluation to long-term results: here is what to expect on the path to better sleep.

1

Consultation & Sleep Study

Your ENT evaluates your sleep apnea severity and CPAP history. A sleep study confirms moderate-to-severe obstructive sleep apnea and helps determine if Inspire may be right for you.

2

DISE Evaluation

Drug-Induced Sleep Endoscopy is a brief sedated procedure that allows your surgeon to view exactly where your airway collapses during sleep and confirm that you are a good candidate for Inspire.

3

Implant Procedure

A short outpatient surgery, typically 60–90 minutes, to place the Inspire device. Two small incisions are made to position the pulse generator and stimulation lead. Most patients go home the same day.

4

Activation & Optimization

The device is activated approximately one month after surgery. Settings are fine-tuned over follow-up visits using your sleep data to ensure optimal therapy and maximum benefit.

What to Expect

Your Inspire Procedure Day at Capital ENT

The Inspire implant is performed as a same-day outpatient procedure, typically at a surgery center where our ENTs hold operating privileges. Here is a clear picture of what the day looks like and what the first month of recovery involves.

Before surgery

Our clinical team provides specific preparation instructions after your procedure is scheduled. Plan to have nothing to eat or drink after midnight the night before. Arrange for a driver, as general anesthesia requires you not to operate a vehicle afterward. Wear comfortable, loose-fitting clothing that opens at the front since your surgeon will be working near the right collarbone.

During the procedure

The operation takes approximately 60 to 90 minutes under general anesthesia. Our surgeon makes two small incisions: one just below the right collarbone, where the pulse generator is placed under the skin, and one under the right side of the jaw, where the stimulation lead is positioned near the hypoglossal nerve. A sensing lead connects the two components to monitor breathing during sleep. The incisions are each a few centimeters long and closed with dissolvable sutures.

Recovery room and discharge

After surgery you spend 1 to 2 hours in the post-anesthesia care unit as anesthesia wears off. Pain is typically mild to moderate and well-managed with over-the-counter acetaminophen combined with ibuprofen or naproxen. Most patients are discharged the same afternoon and feel comfortable enough to return to desk work within 2 to 4 days. Strenuous activity and heavy lifting should be avoided for the first 2 to 3 weeks.

The first month: healing before activation

The device is intentionally not activated on surgery day. The 4-week healing period allows the stimulation lead to integrate with surrounding tissue, which stabilizes the lead position and helps ensure accurate therapy delivery during your first activation visit. Activating too early can lead to suboptimal initial settings.

During this healing period, most patients experience mild soreness that resolves within 1 to 2 weeks. You should avoid:

  • Heavy lifting or vigorous exercise for the first 2 to 3 weeks
  • Raising your right arm above your head repeatedly (strains the chest incision site)
  • Swimming or submerging in water until incisions are fully healed

Activation and optimization

At your 4-week activation appointment, a provider programs the device at a conservative starting level and trains you on the handheld remote. You begin using Inspire every night from this point. Over 2 to 3 follow-up visits spanning the next 2 to 3 months, the therapy level is gradually adjusted based on your response and sleep data downloaded from the device. Most patients reach optimal settings within 3 months of activation.

One advantage of Inspire over surgery that modifies anatomy: settings can always be adjusted. If your sleep changes over time, such as with weight change or aging, the therapy level can be recalibrated at a follow-up visit without additional procedures.

Why Choose Inspire?

Inspire vs. CPAP

See how Inspire therapy compares to traditional CPAP treatment for obstructive sleep apnea.

Inspire CPAP
Mask Required ✓ No mask ✗ Mask required nightly
Noise Level ✓ Silent ▸ Audible machine noise
Portability ✓ Nothing to carry (implanted) ▸ Machine, hose, mask to transport
Compliance ✓ High, simple remote at bedtime ▸ Many patients struggle with adherence
Maintenance ✓ No cleaning or supplies needed ▸ Regular cleaning, filter and mask replacement
Setup ▸ Outpatient surgery required ✓ No surgery, prescription device
Best For CPAP-intolerant patients with moderate-to-severe OSA Patients who tolerate mask therapy well

Not sure which treatment is right for you? Our sleep specialists will evaluate your condition and recommend the best approach during your consultation. See the full CPAP vs Inspire comparison →

Am I a Candidate?

Who Benefits from Inspire Therapy?

Inspire is designed for a specific group of sleep apnea patients. Here is how to know if you may qualify.

Good Candidates

You may be a great fit for Inspire if you have:

  • Moderate-to-severe obstructive sleep apnea (AHI 15–65)
  • Cannot tolerate or do not benefit from CPAP therapy
  • Not significantly overweight (BMI under 40)
  • Over 18 years old
  • No complete concentric collapse at the palate (confirmed by DISE)

May Need a Different Approach

Inspire may not be the best fit if you have:

  • Mild sleep apnea (AHI under 15)
  • BMI over 40
  • Central sleep apnea (not obstructive)
  • Complete concentric palatal collapse on DISE

The best way to find out if you are a candidate is a consultation with one of our sleep specialists. We will review your sleep study and evaluate your airway to recommend the right treatment for you.

Patient Story

Hear From Our Inspire Patients

Watch how Inspire therapy has transformed the lives of our patients: better sleep, more energy, and freedom from CPAP.

Schedule Your Consultation
Recovery

What to Expect After Inspire Surgery

A clear timeline so you know exactly what to expect from surgery day through long-term use.

1
Day of Surgery

Outpatient Procedure & Rest

The implant procedure typically takes 60–90 minutes under general anesthesia. You go home the same day. Plan to rest and avoid strenuous activity. Some soreness at the incision sites is normal.

2
Weeks 1–2

Initial Healing

Mild soreness at the incision sites gradually improves. Most patients return to desk work and light daily activities within a few days. Avoid heavy lifting and vigorous exercise during this period.

3
Month 1

Device Activation

You return to the office for your activation appointment. Your provider turns on the Inspire device and configures the initial therapy settings. You begin using the device nightly with your handheld remote.

4
Months 2–3

Optimization

Follow-up visits allow your provider to review your sleep data and fine-tune the therapy settings. Most patients notice significant improvement in sleep quality and daytime energy during this period.

Long-Term

Nightly Use & Annual Follow-Ups

Simply use your remote to turn Inspire on at bedtime and off in the morning. Annual follow-up appointments ensure your therapy remains optimized. The battery lasts approximately 11 years.

The Evidence

Long-Term Outcomes: What the Research Shows

Inspire is the most extensively studied upper airway stimulation therapy for obstructive sleep apnea, with over a decade of published clinical data from both controlled trials and large real-world registries.

The STAR Trial

The pivotal Inspire clinical trial, the STAR trial published in the New England Journal of Medicine (Strollo et al., 2014), enrolled 126 adults with moderate-to-severe OSA who had failed CPAP therapy. At 12 months:

  • 66% of participants met the pre-specified surgical success criterion (at least 50% AHI reduction with post-treatment AHI below 20 events per hour)
  • Snoring severity scores improved dramatically: 89% of bed partners reported no snoring or soft snoring, compared to 4% at baseline
  • Daytime sleepiness (Epworth Sleepiness Scale) improved significantly, with patients moving from pathological to normal ranges
  • Functional outcomes, measured by the Functional Outcomes of Sleep Questionnaire, improved across all domains including work performance and activity level

Long-term durability

Long-term follow-up of STAR trial participants and patients in subsequent open-label extension studies has confirmed that Inspire results are durable. Outcomes at 3 and 5 years remained consistent with 12-month results for patients who continued nightly therapy, with no meaningful erosion of AHI benefit in appropriately selected patients.

The ADHERE registry, which tracks real-world Inspire outcomes across implanting centers in the United States and Europe, has published data consistently showing results comparable to the pivotal trial across a broader patient population. The registry's findings reflect the benefit of systematic pre-operative DISE evaluation: careful screening identifies the patients most likely to respond well.

Capital ENT outcomes

At Capital ENT, our Inspire patients achieve an average 84% reduction in AHI, exceeding the STAR trial median. We attribute this to careful patient selection, consistent pre-operative DISE evaluation, and close post-activation follow-up to optimize therapy settings over the months following implantation. We track outcomes for each patient at annual follow-up appointments.

Inspire is not guaranteed to achieve surgical success in every patient. During your consultation, our team will give you a realistic expectation based on your anatomy, OSA severity, BMI, and DISE findings.

Insurance & Cost Information

Inspire therapy is a significant investment in your quality of life, and most patients find it well-covered by insurance. Our team handles the authorization process so you can focus on feeling better.

  • Most major insurance plans accepted, including Medicare
  • Prior authorization managed by our team before surgery is scheduled
  • Documented sleep apnea diagnosis and failed CPAP trial typically required for coverage
  • HSA and FSA accounts accepted

Find Out If You Qualify

Schedule a consultation to determine if Inspire is right for you. Our team will verify your insurance benefits and walk you through the process.

Schedule a Consultation
Or call us at 512-339-4040
Common Questions

Inspire Therapy FAQ

Inspire is an FDA-approved implantable device that treats moderate-to-severe obstructive sleep apnea. A small pulse generator, placed under the skin of the upper chest, monitors your breathing and delivers mild stimulation to the hypoglossal nerve. This stimulation gently moves your tongue and other airway muscles forward to keep the airway open while you sleep. You simply turn it on at bedtime with a small handheld remote and turn it off when you wake up.
Inspire is designed for adults with moderate-to-severe obstructive sleep apnea (AHI 15–65) who cannot tolerate or do not benefit from CPAP therapy. Candidates should have a BMI under 40. A Drug-Induced Sleep Endoscopy (DISE) is required to confirm that you do not have complete concentric collapse at the palate level, which would make the therapy less effective. Our team will evaluate your sleep study results and medical history during a consultation to determine if you qualify.
Most major insurance plans, including Medicare, cover Inspire therapy when medical criteria are met. Coverage typically requires a documented diagnosis of moderate-to-severe obstructive sleep apnea and evidence that CPAP has been tried without adequate success. Capital ENT's team will verify your insurance benefits and obtain any necessary authorizations before scheduling surgery.
DISE stands for Drug-Induced Sleep Endoscopy. It is a brief procedure performed under light sedation in which a thin, flexible camera is passed through the nose to observe exactly where and how the airway collapses during sleep. DISE is required before Inspire implantation because the therapy works best for certain patterns of collapse. Patients with complete concentric collapse at the palate level are typically not good candidates for Inspire.
The Inspire pulse generator battery lasts approximately 11 years. When the battery reaches the end of its life, it is replaced through a simple outpatient procedure that involves a small incision at the original chest site. The stimulation lead does not need to be replaced.
Most patients return home the same day after Inspire surgery. Expect mild incision pain around the chest and under the jaw, some swelling, and limited overhead arm movement for about 2 weeks. Tylenol with ibuprofen or Aleve typically controls pain well. The device is not activated immediately; activation occurs at a follow-up appointment about 1 month after surgery, once the incisions have fully healed.
Clinical studies show Inspire therapy significantly reduces sleep apnea events for most appropriately selected patients. In the STAR trial (the pivotal clinical study published in the New England Journal of Medicine), patients had a median 78% reduction in apnea-hypopnea index after one year, and the majority of bed partners reported substantial improvement in snoring. Capital ENT has implanted Inspire for over 10 years and tracks outcomes closely for each patient.
Inspire is a generally well-tolerated outpatient procedure. The most common temporary effects are incision soreness, swelling, and bruising at the chest and under-the-jaw sites. Less common risks include tongue weakness or temporary numbness, device-site infection, lead movement requiring revision, and rare cases of pneumothorax. Capital ENT's 10+ years of Inspire experience contributes to favorable safety outcomes.
Yes. Current-generation Inspire IV and V systems are cleared for full-body 1.5T and 3.0T MRI under specific safe-scan conditions defined by the manufacturer. Older Inspire systems may have more limited MRI compatibility. Always tell your MRI provider that you have an Inspire device so they can confirm scan parameters and put the device in MRI mode beforehand.
Most patients use Inspire every night starting about 1 month after surgery, once the device is activated by a sleep medicine physician. Initial settings are conservative; the stimulation level is gradually adjusted over several follow-up visits and a titration sleep study to optimize the therapy. Most patients reach effective treatment within 2–3 months of activation.
Daily Life

Living With Your Inspire Device

Inspire is designed to fit seamlessly into normal life. Here is what patients most often ask about day-to-day experience with the implant.

Your nightly routine

Before bed, press the button on your Inspire remote to activate the device. A programmable delay, typically 30 minutes, allows you to fall asleep before stimulation begins. Press the remote in the morning to turn it off. The entire routine takes seconds. Most patients find it second nature within the first week, and many report that the simplicity compared to nightly CPAP setup is itself a quality-of-life improvement.

Travel and airport security

The Inspire pulse generator contains metal components and will trigger airport security screening equipment, including walk-through metal detectors. Inspire provides a medical device identification card to carry when flying. Full-body millimeter-wave scanners used at most TSA checkpoints are compatible with the device. Inform security officers of your implant before entering any scanner. Our team reviews travel considerations at every activation appointment.

Physical activity

After the initial healing period of 4 to 6 weeks, there are no activity restrictions related to Inspire. Patients run, swim, cycle, lift weights, and travel internationally without limitation. The pulse generator sits below the skin of the upper chest and does not interfere with upper body movement once healing is complete. Many patients report that their capacity for activity improves substantially once they are sleeping well.

Medical and dental procedures

Before any procedure involving electrosurgery, diathermy, or certain medical imaging, inform the provider that you have an Inspire implant. Current-generation Inspire IV and V systems are cleared for 1.5T and 3.0T full-body MRI under manufacturer-specified safe-scan conditions. Dental procedures using ultrasonic scalers require the device to be in therapy-off mode during the procedure. Our team can provide your device specifications for any treating provider who needs documentation.

Sleep position

Inspire therapy works in any sleep position: back, side, or stomach. You are not restricted to a particular position the way patients using positional therapy devices are. Most patients report that sleep comfort improves progressively over the first 2 to 3 months as therapy settings are gradually optimized to their anatomy. Bed partners typically notice the change first: the snoring stops.

Battery and long-term device management

The Inspire pulse generator battery lasts approximately 11 years under typical nightly use. When the battery reaches end of life, it is replaced through a brief outpatient procedure using the same incision as the original implant. The stimulation lead and sensing lead do not need to be replaced. Patients typically transition from one generator to the next with minimal disruption. Annual follow-up visits allow us to monitor battery life and download therapy data so there are no surprises.

Reviewed by Dr. Zachary Wassmuth, Board-Certified Otolaryngologist

Ready for Sleep Without a Mask?

Schedule a consultation to find out if Inspire is right for you. Same-day and next-day appointments are often available at our four Central Texas locations.

Book Appointment